SCHEMBL8772456

SCHEMBL8772456

COc1ccc([S+]([O-])C2CC(=O)N2CC(=O)CCc2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
TP53 P04637 1/20 0.43
MAPT P10636 2/20 0.42
PLAAT3 P53816 1/20 0.42
PLAAT5 Q96KN8 1/20 0.42
PLAAT2 Q9NWW9 1/20 0.42
PLAAT4 Q9UL19 1/20 0.42
F2RL1 P55085 1/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 6/20 0.40
HSD17B10 Q99714 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
ALOX5 P09917 1/20 0.39
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8772382 0.89 HMOX1 (0.40) NPC1ATMALDH1A1POLBGAA
SCHEMBL8443497 0.89 HMOX1 (0.40) NPC1ATMALDH1A1POLBGAA
SCHEMBL8443496 0.89 HMOX1 (0.40) NPC1ATMALDH1A1POLBGAA
SCHEMBL8442244 0.89 HMOX1 (0.40) NPC1ATMALDH1A1POLBGAA
SCHEMBL8772457 0.89 RAB9A (0.42) NPC1RAB9ATP53MAPTALDH1A1
SCHEMBL8772502 0.87 ALOX5 (0.42) NPC1RAB9ATP53PLAAT3PLAAT5
SCHEMBL8440303 0.87 TP53 (0.45) NPC1RAB9ATP53MAPTPLAAT3
SCHEMBL8772438 0.84 HCRTR1 (0.42) ALOX5POLBGAA
SCHEMBL8441221 0.83 NPC1 (0.49) NPC1RAB9ATP53MAPTALDH1A1
SCHEMBL8102560 0.81 HMOX1 (0.40) NPC1ALDH1A1ALOX5POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799200-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-10-08 EP claimed
WO-1996019451-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO claimed
EP-0799200-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-10-08 EP disclosed
WO-1996019451-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO disclosed